Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

June 26, 2020

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

News Industry News

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

May 07, 2019

News Industry News

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

May 06, 2019

News Industry News

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

April 16, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

November 07, 2018

News Industry News

Intact Vascular's Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial Commences Enrollment with First Implant of the Tack Endovascular System®

February 13, 2017

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Industry News

FDA approves Repatha to treat certain patients with high cholesterol

August 28, 2015

News Industry News

FDA approves new antiplatelet drug used during heart procedure

June 24, 2015

Advertisement

Intact Vascular Announces Positive One-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

Intact Vascular's Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) Clinical Trial Commences Enrollment with First Implant of the Tack Endovascular System®

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

FDA approves Repatha to treat certain patients with high cholesterol

FDA approves new antiplatelet drug used during heart procedure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content